Published in J Neurol on March 18, 2005
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain (2007) 2.58
Rates of cerebral atrophy differ in different degenerative pathologies. Brain (2007) 1.90
Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res Ther (2014) 0.93
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging (2014) 0.89
Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. J Neurol (2014) 0.87
Analysis of the substantia innominata volume in patients with Parkinson's disease with dementia, dementia with lewy bodies, and Alzheimer's disease. J Mov Disord (2011) 0.76
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry (1993) 3.95
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 1.85
MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. AJNR Am J Neuroradiol (2002) 1.59
Cholinergic dysfunction in diseases with Lewy bodies. Neurology (2000) 1.58
MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report. AJNR Am J Neuroradiol (1996) 1.46
Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology (1993) 1.05
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport (1994) 1.01
Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients. Dement Geriatr Cogn Disord (2003) 0.82
Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease? Trends Pharmacol Sci (1996) 0.78
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging (2009) 1.77
Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2005) 1.65
MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. AJNR Am J Neuroradiol (2002) 1.59
Evaluation of pharmacogenetic algorithm for warfarin dose requirements in Japanese patients. Circ J (2010) 1.49
SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One (2013) 1.23
A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol (2008) 1.22
Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. Cancer Immunol Immunother (2007) 1.14
CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. J Immunol (2009) 1.13
Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus. J Am Geriatr Soc (2009) 1.09
Cerebral microbleeds in Alzheimer's disease. J Neurol (2003) 1.07
Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci (2005) 1.06
Gallium-67 accumulation to the tumor thrombus in anaplastic thyroid cancer. Ann Nucl Med (2003) 1.03
Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity. J Immunol (2006) 1.02
Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI. Dement Geriatr Cogn Disord (2002) 1.02
SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease. J Neuroimaging (2006) 0.97
Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr J (2011) 0.96
Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study. Geriatr Gerontol Int (2012) 0.96
Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring) (2008) 0.95
Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT. J Neurol Sci (2006) 0.95
Sigmoid volvulus showing "a whirl sign" on CT. Intern Med (2006) 0.94
The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol (2009) 0.93
Transient lower esophageal sphincter relaxations (TLESRs) are the major mechanism of gastroesophageal reflux but are not the cause of reflux disease. Dig Dis Sci (2005) 0.93
Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. J Neurol (2011) 0.92
MR features of the substantia innominata and therapeutic implications in dementias. Neurobiol Aging (2006) 0.92
Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease. Geriatr Gerontol Int (2011) 0.91
The effect of education on rCBF changes in Alzheimer's disease: a longitudinal SPECT study. Eur J Nucl Med Mol Imaging (2008) 0.89
Neuroanatomical correlates of unawareness of memory deficits in early Alzheimer's disease. Dement Geriatr Cogn Disord (2008) 0.88
[Elderly case of isolated ACTH deficiency presenting with depression and digestive symptoms]. Nihon Ronen Igakkai Zasshi (2007) 0.88
Voxel-based magnetic resonance imaging study of structural brain changes in patients with idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord (2011) 0.87
Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound: comparative study with SPIO-MRI. Hepatol Res (2004) 0.86
The appearance of rosette-like esophageal folds ("esophageal rosette") in the lower esophagus after a deep inspiration is a characteristic endoscopic finding of primary achalasia. J Gastroenterol (2009) 0.86
Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol (2009) 0.86
Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide. Int J Cancer (2005) 0.85
Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dement Geriatr Cogn Disord (2005) 0.85
Nilvadipine prevents cognitive decline of patients with mild cognitive impairment. Int J Geriatr Psychiatry (2007) 0.85
CCR7 ligands up-regulate IL-23 through PI3-kinase and NF-κ B pathway in dendritic cells. J Leukoc Biol (2012) 0.84
Decreased cerebral blood flow and prognosis of Alzheimer's disease: a multicenter HMPAO-SPECT study. Ann Nucl Med (2007) 0.84
Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion. Nucl Med Commun (2008) 0.84
New semiquantitative assessment of 123I-FP-CIT by an anatomical standardization method. Ann Nucl Med (2006) 0.84
Frontal Assessment Battery and brain perfusion images in amnestic mild cognitive impairment. Geriatr Gerontol Int (2010) 0.84
[Hypertrophic cardiomyopathy with mid-ventricular obstruction complicated by apical aneurysm appearing as delayed contrast hyperenhancement on magnetic resonance imaging: two case reports]. J Cardiol (2003) 0.84
Association between ApoE phenotypes and telomere erosion in Alzheimer's disease. J Gerontol A Biol Sci Med Sci (2011) 0.83
Vascular risk factors and progression in Alzheimer's disease. Geriatr Gerontol Int (2010) 0.83
Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells. Immunology (2004) 0.83
Cerebral microbleeds in Binswanger's disease: a gradient-echo T2*-weighted magnetic resonance imaging study. Neurosci Lett (2003) 0.83
Japanese version of the Test Your Memory as a screening test in a Japanese memory clinic. Psychiatry Res (2011) 0.83
The ratio of the maximum high attenuation area dimension to the maximum tumor dimension may be an index of the presence of lymph node metastasis in lung adenocarcinomas 3 cm or smaller on high-resolution computed tomography. J Thorac Oncol (2007) 0.83
Image quality using dynamic MR imaging of the temporomandibular joint with true-FISP sequence. Magn Reson Med Sci (2007) 0.83
Value of analyzing deep gray matter and occipital lobe perfusion to differentiate dementia with Lewy bodies from Alzheimer's disease. Ann Nucl Med (2009) 0.82
Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients. Dement Geriatr Cogn Disord (2003) 0.82
Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease. Neurosci Lett (2002) 0.82
Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment. Nucl Med Commun (2007) 0.81
Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease. Neurosci Lett (2005) 0.81
Prevalence of coexisting diseases in patients with Alzheimer's disease. Geriatr Gerontol Int (2010) 0.81
Defective triggering of secondary peristalsis in patients with non-erosive reflux disease. J Gastroenterol Hepatol (2007) 0.81
Irradiation up-regulates CD80 expression through induction of tumour necrosis factor-alpha and CD40 ligand expression on B lymphoma cells. Immunology (2002) 0.81
The role of tumor necrosis factor-alpha in cognitive improvement after peroxisome proliferator-activator receptor gamma agonist pioglitazone treatment in Alzheimer's disease. J Am Geriatr Soc (2010) 0.80
Subgroups of Alzheimer's disease associated with diabetes mellitus based on brain imaging. Dement Geriatr Cogn Disord (2013) 0.80
Peripheral T-cell lymphoma presenting as myelofibrosis with the expression of basic fibroblast growth factor. Geriatr Gerontol Int (2009) 0.80
Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model. Cancer Immunol Immunother (2015) 0.80
Delayed contrast enhancement in a patient with perimyocarditis on contrast-enhanced cardiac MRI: case report. Int J Cardiovasc Imaging (2005) 0.80
Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome. Am J Med Genet A (2014) 0.79